| Dr Chayanin Musikasinthorn, MD | |
|
516 East Nizhoni Blvd., Gallup, NM 87301-1337 | |
| (505) 722-1000 | |
| (505) 722-1650 |
| Full Name | Dr Chayanin Musikasinthorn |
|---|---|
| Gender | Female |
| Speciality | General Surgery |
| Experience | 18 Years |
| Location | 516 East Nizhoni Blvd., Gallup, New Mexico |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1295930881 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208600000X | Surgery | MDR5069 (Hawaii) | Secondary |
| 208600000X | Surgery | MD14862 (Hawaii) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Gallup Indian Medical Center | Gallup, NM | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Dhhs,phs,naihs, Gallup Indian Medical Center | 3173436409 | 100 |
| Queens University Medical Group | 2466831557 | 543 |
News Archive
A study led by researchers at Vanderbilt University Medical Center and the University of Arizona College of Pharmacy has generated the first comprehensive catalog of diseases associated with variations in human leukocyte antigen genes that regulate the body's immune system.
Panic disorder is a severe form of anxiety in which the affected individual feels an abrupt onset of fear, often accompanied by profound physical symptoms of discomfort. Scientists have known from studying twins that genes contribute to the risk of panic disorder, but very little is known about which specific genes are involved.
Wyeth Pharmaceuticals, a division of Wyeth (NYSE: WYE) and Ambrx Inc. today announced the formation of a worldwide alliance to discover, develop, and commercialize protein drug candidates for three undisclosed targets in multiple therapeutic areas. The alliance will capitalize on Ambrx's recent breakthroughs in applying its protein medicinal chemistry platform to proteins produced in mammalian cells such as antibodies and antibody-toxin conjugates.
InterMune, Inc. today announced results of all three cohorts from a 15-day Phase 1b multiple-ascending-dose (MAD) study of low doses of danoprevir (also known as RG7227 and ITMN-191) boosted by low-dose ritonavir (RTV) in patients chronically infected with hepatitis C virus (HCV) genotype-1.
Merck Consumer Care today announced results of a head-to-head clinical study showing that ZEGERID OTC- offers greater and faster acid control than Prevacid- 24HR. While acid control is an industry standard measure for acid-reducing drugs, greater and faster acid control does not imply greater and faster heartburn symptom relief.
› Verified 4 days ago
| Entity Name | Dhhs,phs,naihs, Gallup Indian Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1225002322 PECOS PAC ID: 3173436409 Enrollment ID: O20031111000840 |
News Archive
A study led by researchers at Vanderbilt University Medical Center and the University of Arizona College of Pharmacy has generated the first comprehensive catalog of diseases associated with variations in human leukocyte antigen genes that regulate the body's immune system.
Panic disorder is a severe form of anxiety in which the affected individual feels an abrupt onset of fear, often accompanied by profound physical symptoms of discomfort. Scientists have known from studying twins that genes contribute to the risk of panic disorder, but very little is known about which specific genes are involved.
Wyeth Pharmaceuticals, a division of Wyeth (NYSE: WYE) and Ambrx Inc. today announced the formation of a worldwide alliance to discover, develop, and commercialize protein drug candidates for three undisclosed targets in multiple therapeutic areas. The alliance will capitalize on Ambrx's recent breakthroughs in applying its protein medicinal chemistry platform to proteins produced in mammalian cells such as antibodies and antibody-toxin conjugates.
InterMune, Inc. today announced results of all three cohorts from a 15-day Phase 1b multiple-ascending-dose (MAD) study of low doses of danoprevir (also known as RG7227 and ITMN-191) boosted by low-dose ritonavir (RTV) in patients chronically infected with hepatitis C virus (HCV) genotype-1.
Merck Consumer Care today announced results of a head-to-head clinical study showing that ZEGERID OTC- offers greater and faster acid control than Prevacid- 24HR. While acid control is an industry standard measure for acid-reducing drugs, greater and faster acid control does not imply greater and faster heartburn symptom relief.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Chayanin Musikasinthorn, MD P.o. Box 1337, Gallup, NM 87305-1337 Ph: (505) 722-1000 | Dr Chayanin Musikasinthorn, MD 516 East Nizhoni Blvd., Gallup, NM 87301-1337 Ph: (505) 722-1000 |
News Archive
A study led by researchers at Vanderbilt University Medical Center and the University of Arizona College of Pharmacy has generated the first comprehensive catalog of diseases associated with variations in human leukocyte antigen genes that regulate the body's immune system.
Panic disorder is a severe form of anxiety in which the affected individual feels an abrupt onset of fear, often accompanied by profound physical symptoms of discomfort. Scientists have known from studying twins that genes contribute to the risk of panic disorder, but very little is known about which specific genes are involved.
Wyeth Pharmaceuticals, a division of Wyeth (NYSE: WYE) and Ambrx Inc. today announced the formation of a worldwide alliance to discover, develop, and commercialize protein drug candidates for three undisclosed targets in multiple therapeutic areas. The alliance will capitalize on Ambrx's recent breakthroughs in applying its protein medicinal chemistry platform to proteins produced in mammalian cells such as antibodies and antibody-toxin conjugates.
InterMune, Inc. today announced results of all three cohorts from a 15-day Phase 1b multiple-ascending-dose (MAD) study of low doses of danoprevir (also known as RG7227 and ITMN-191) boosted by low-dose ritonavir (RTV) in patients chronically infected with hepatitis C virus (HCV) genotype-1.
Merck Consumer Care today announced results of a head-to-head clinical study showing that ZEGERID OTC- offers greater and faster acid control than Prevacid- 24HR. While acid control is an industry standard measure for acid-reducing drugs, greater and faster acid control does not imply greater and faster heartburn symptom relief.
› Verified 4 days ago
Charles J.s. Guimaraes, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 1900 Red Rock Dr., Rehoboth Mckinley Christian Health Care Services, Gallup, NM 87301 Phone: 505-863-7200 | |
Dr. Loretta L Christensen, MD Surgery Medicare: Medicare Enrolled Practice Location: 516 East Nizhoni Blvd., Gallup, NM 87301 Phone: 505-722-1000 Fax: 505-722-1650 | |
Maria P Gobencion, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 516 E. Nizhoni Blvd., Gallup, NM 87301 Phone: 505-722-1000 Fax: 505-722-1650 | |
Jack B Fralinger, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 516 E. Nizhoni Blvd., Gallup, NM 87301 Phone: 505-722-1000 Fax: 505-722-1226 | |
Kimberly Marie Collins, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 1900 Redrock Dr, Gallup, NM 87301 Phone: 505-863-7200 | |
William L Shankel, M.D. Surgery Medicare: Medicare Enrolled Practice Location: 516 East Nizhoni Blvd., Gallup, NM 87301 Phone: 505-722-1000 Fax: 505-722-1650 |